Sign In
Buy ANTM
$459.54
-37.89 (-7.62%)
At Close: Jul 20, 2022
Expert Ratings for Anthem
03:37pm, Friday, 27'th May 2022 Benzinga
Analysts have provided the following ratings for Anthem (NYSE:ANTM) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
5
2
0
0
Last 30D
0
Anthem (ANTM) Gains But Lags Market: What You Should Know
10:00pm, Thursday, 26'th May 2022 Zacks Investment Research
Anthem (ANTM) closed the most recent trading day at $512.43, moving +1.52% from the previous trading session.
Anthem Announces Appearance at Upcoming Conference
04:05pm, Thursday, 26'th May 2022
INDIANAPOLIS--(BUSINESS WIRE)--Anthem, Inc. (NYSE: ANTM) announced today that senior management is scheduled to present at the 38th Annual Bernstein Strategic Decisions Conference in New York City on
The Zacks Analyst Blog Highlights Johnson & Johnson, Walt Disney, NextEra Energy, The Home Depot and Anthem
10:56am, Thursday, 26'th May 2022 Zacks Investment Research
Johnson & Johnson, Walt Disney, NextEra Energy, The Home Depot and Anthem have been included in this Analyst Blog.
Top Research Reports for Johnson & Johnson, Walt Disney & NextEra Energy
07:51pm, Wednesday, 25'th May 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), The Walt Disney Company (DIS) and NextEra Energy, Inc. (NEE).
Why Is Anthem (ANTM) Down 8.2% Since Last Earnings Report?
05:01pm, Friday, 20'th May 2022 Zacks Investment Research
Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Will the Retail Rout Continue? Key Companies Report Q1 Results
04:14pm, Friday, 13'th May 2022 Investing.com
Select Medical (SEM) Shares Up on Q1 Earnings & Revenue Beat
12:43pm, Friday, 13'th May 2022 Zacks Investment Research
Select Medical's (SEM) first-quarter earnings benefit from higher patient visits and sound segmental contributions to revenues, partly offset by elevated labor expenses.
Is This Fast-Growing Dividend Stock a Buy?
10:56am, Wednesday, 11'th May 2022 The Motley Fool
Anthem continues to generate double-digit revenue and earnings growth.
Mednax (MD) Down 20% Despite Q1 Earnings Beat on Patient Volumes
03:35pm, Tuesday, 10'th May 2022 Zacks Investment Research
Mednax (MD) continues to anticipate revenues of $2 billion and adjusted EBITDA of at least $270 million for 2022.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
10:20am, Tuesday, 10'th May 2022 Zacks Investment Research
Sector ETF report for IHF
Vanguard Health Care Fund's Top 5 Trades in the 1st Quarter
05:05pm, Monday, 09'th May 2022
The Vanguard Health Care Fund (Trades, Portfolio) recently disclosed its first quarter 2022 portfolio, revealing that its top five trades for the quarter included a new position in Zoetis Inc. ( ZTS ,
Nonprofit company vows to produce generic insulin and sell it for $1 a day
04:11pm, Monday, 09'th May 2022 MarketWatch
Success is far from guaranteed, given that the established players all have a strong financial interest in seeing Civica’s efforts fail.
Can This Healthcare Stock Insure Your Portfolio?
11:40am, Tuesday, 03'rd May 2022
Anthem Inc (NYSE:ANTM) has added 7.5% in 2022 so far, and nearly 30% in the past 12 months.
IYH: Diversified Healthcare ETF Suitable For Short Term Investment
04:24am, Tuesday, 03'rd May 2022 Seeking Alpha
The IYH ETF has posted strong price returns over the medium and long term, but generated 1% yield. Read why I'll prefer to make IYH a trading instrument.
